GE HealthCare Technologies (NasdaqGS:GEHC) has dosed the first patient in its global LUMINA Phase 2/3 trial of mangaciclanol, ...
GE HealthCare Technologies Inc. (NASDAQ:GEHC) is one of the best NASDAQ stocks with the highest upside potential.
Contrast-enhanced MRI demonstrated a sensitivity of 91.3% and a specificity of 68.8% in assessing high-risk breast lesions, with the potential to help patients avoid unnecessary surgery, according to ...
BERLIN--(BUSINESS WIRE)--Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an ...
Approval marks a major milestone in reducing gadolinium exposure while maintaining diagnostic performance, aligning with clinical guidance to use the lowest effective dose MONTREAL, April 17, 2026 ...
A new magnetic resonance imaging (MRI) contrast agent being tested by researchers at Case Western Reserve University not only pinpoints breast cancers at early stages but differentiates between ...
BodyView Preventive MRI provides patients with a smooth, professional — and perhaps even lifesaving — experience.
Please provide your email address to receive an email when new articles are posted on . A novel, composite score based on MRI findings may aid in surgical decision-making for patients with brachial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results